First Manhattan’s Sanofi Contingent Value Rights GCVRZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-47
| Closed | – | – | 1529 |
|
|
2019
Q4 | $0 | Hold |
47
| – | – | ﹤0.01% | 1435 |
|
|
2019
Q3 | $0 | Sell |
47
-93
| -66% | -$50 | ﹤0.01% | 1470 |
|
|
2019
Q2 | $0 | Hold |
140
| – | – | ﹤0.01% | 1501 |
|
|
2019
Q1 | $0 | Hold |
140
| – | – | ﹤0.01% | 1521 |
|
|
2018
Q4 | $0 | Hold |
140
| – | – | ﹤0.01% | 1516 |
|
|
2018
Q3 | $0 | Hold |
140
| – | – | ﹤0.01% | 1492 |
|
|
2018
Q2 | $0 | Hold |
140
| – | – | ﹤0.01% | 1487 |
|
|
2018
Q1 | $0 | Hold |
140
| – | – | ﹤0.01% | 1547 |
|
|
2017
Q4 | $0 | Hold |
140
| – | – | ﹤0.01% | 1587 |
|
|
2017
Q3 | $0 | Hold |
140
| – | – | ﹤0.01% | 1571 |
|
|
2017
Q2 | $0 | Hold |
140
| – | – | ﹤0.01% | 1545 |
|
|
2017
Q1 | $0 | Hold |
140
| – | – | ﹤0.01% | 1520 |
|
|
2016
Q4 | $0 | Hold |
140
| – | – | ﹤0.01% | 1529 |
|
|
2016
Q3 | $0 | Hold |
140
| – | – | ﹤0.01% | 1561 |
|
|
2016
Q2 | $0 | Hold |
140
| – | – | ﹤0.01% | 1604 |
|
|
2016
Q1 | $0 | Hold |
140
| – | – | ﹤0.01% | 1543 |
|
|
2015
Q4 | $0 | Hold |
140
| – | – | ﹤0.01% | 1582 |
|
|
2015
Q3 | $0 | Hold |
140
| – | – | ﹤0.01% | 1561 |
|
|
2015
Q2 | $0 | Hold |
140
| – | – | ﹤0.01% | 1575 |
|
|
2015
Q1 | $0 | Hold |
140
| – | – | ﹤0.01% | 1603 |
|
|
2014
Q4 | $0 | Hold |
140
| – | – | ﹤0.01% | 1615 |
|
|
2014
Q3 | $0 | Hold |
140
| – | – | ﹤0.01% | 1544 |
|
|
2014
Q2 | $0 | Hold |
140
| – | – | ﹤0.01% | 1521 |
|
|
2014
Q1 | $0 | Hold |
140
| – | – | ﹤0.01% | 1535 |
|
|
2013
Q4 | $0 | Hold |
140
| – | – | ﹤0.01% | 1476 |
|
|
2013
Q3 | $0 | Hold |
140
| – | – | ﹤0.01% | 1469 |
|
|
2013
Q2 | $0 | Buy |
+140
| New | +$246 | ﹤0.01% | 1419 |
|
First Manhattan's GCVRZ Position: Q1 2020 in Review
First Manhattan sold out of Sanofi Contingent Value Rights (GCVRZ) in Q1 2020, closing a stake of 47 shares.
First Manhattan first reported a position in GCVRZ in Q2 2013 and held it in 27 quarters. The position peaked at $0 in Q4 2019. 2 funds tracked by Wall St. Rank hold GCVRZ as of Q1 2020.
- First Manhattan reported no remaining Sanofi Contingent Value Rights position as of Q1 2020 after selling out during the quarter.
- First Manhattan sold 47 Sanofi Contingent Value Rights shares in Q1 2020.
- First Manhattan first reported a position in Sanofi Contingent Value Rights in Q2 2013 and held it in 27 quarters.
- First Manhattan's Sanofi Contingent Value Rights position peaked at $0 in Q4 2019.
- 2 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q1 2020.
Based on First Manhattan's 13F filing for Q1 2020, filed 6 May 2020.